comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders.
about
Sexual behaviour and HPV infections in 18 to 29 year old women in the pre-vaccine era in the NetherlandsA study of Amplicor human papillomavirus DNA detection in the atypical squamous cells of undetermined significance-low-grade squamous intraepithelial lesion triage study.Analytical and clinical performances of a restriction fragment mass polymorphism assay for detection and genotyping of a wide spectrum of human papillomaviruses.High-resolution melting molecular signatures for rapid identification of human papillomavirus genotypesHuman papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with Amplicor HPV and Hybrid Capture 2 assays for detection of high-grade lesions of the uterine cervixComparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples.Assessment of MagNA pure LC extraction system for detection of human papillomavirus (HPV) DNA in PreservCyt samples by the Roche AMPLICOR and LINEAR ARRAY HPV tests.Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the roche linear array HPV genotyping test.Performance evaluation of manual and automated (MagNA pure) nucleic acid isolation in HPV detection and genotyping using Roche Linear Array HPV TestSimultaneous amplification and identification of 25 human papillomavirus types with Templex technologyAgreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 assay in detection of high-risk human papillomavirus and diagnosis of biopsy-confirmed high-grade cervical disease.Prospective evaluation of the Hybrid Capture 2 and AMPLICOR human papillomavirus (HPV) tests for detection of 13 high-risk HPV genotypes in atypical squamous cells of uncertain significance.Human papillomavirus quantification in urine and cervical samples by using the Mx4000 and LightCycler general real-time PCR systemsComparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results.Detection of high-risk papillomavirus DNA with commercial invader-technology-based analyte-specific reagents following automated extraction of DNA from cervical brushings in ThinPrep mediaPilot study of prevalence of high-risk human papillomavirus genotypes in Israeli Jewish women referred for colposcopic examination.Comparison of GP5+/6+-PCR and SPF10-line blot assays for detection of high-risk human papillomavirus in samples from women with normal cytology results who develop grade 3 cervical intraepithelial neoplasia.Identification of key genes associated with cervical cancer by comprehensive analysis of transcriptome microarray and methylation microarray.High-risk and multiple human papillomavirus (HPV) infections in cancer-free Jamaican women.Looking ahead: a case for human papillomavirus testing of self-sampled vaginal specimens as a cervical cancer screening strategy.Detection and genotyping of human papillomavirus in self-obtained cervicovaginal samples by using the FTA cartridge: new possibilities for cervical cancer screening.Human Papillomavirus (HPV) Detection in Cytologic Specimens: Similarities and Differences of Available Methodology.Commercially available assays for multiplex detection of alpha human papillomaviruses.An in vitro selection scheme for oligonucleotide probes to discriminate between closely related DNA sequences.Human papillomavirus genotype distribution in cervical samples among vaccine naïve Barbados women.Emerging biomarkers in the detection, diagnosis and management of cervical dysplasia and carcinoma.
P2860
Q33384636-9A8680F8-550A-4FC8-9A16-541B77BD86C9Q33580897-28D972F2-27DE-4E1B-A947-49813BCE428FQ33803013-C7E65C4A-6774-4DB2-B152-0F025E08B904Q34390791-17CCA97A-D797-4E4C-9D0E-CDF7A1033E80Q34487394-4C4A8A28-7583-426E-8EA2-AD8C862EA4A6Q34719578-D1ECCE24-9E1E-4863-9431-618CB674BEDAQ34720093-93F53367-0717-4570-BAC1-9D60A23534B4Q35073364-20274DB1-3A85-4469-BA74-CF3A562652A1Q35113674-56F21BCD-90DB-4B72-87BF-840BB2E256BFQ35220805-C315479E-7D81-4ACF-BD8D-30B7D8F2DA17Q35690377-49869407-FA4D-4BD9-87D0-148DC6DB5F6CQ35690441-E74F5CFC-23CF-43F9-A0E7-C012D73665E2Q35690716-F4DD8A45-07DA-4889-8732-1280253BDDAFQ35913775-911074EA-55E3-4E9C-A75E-91E5459ADD7EQ36314565-401F1660-1C60-47C9-99AD-84132C1389CCQ36673115-8CB75946-503D-4C60-9A63-050E15AE8932Q36933532-6751C31B-C4B9-4511-8EA9-E3C4C1295DB5Q37002191-92FD27A8-9F41-4EC6-B38B-F5D902AA132AQ37089452-82012E46-9B44-41FB-89CE-F78C0C19C1D8Q37195121-472F7B2F-BECA-4043-B535-E581ACF09327Q37302153-EAA5050A-DC03-4FE2-8195-88EF6F9699F4Q37713244-7C9688EA-030C-410C-AB80-D649C6A0768AQ37800921-221728F4-67AF-4AA6-984E-6F22AAE6CD34Q38302836-6D6817A0-0CA6-4246-A3CB-EB4173308D09Q40044496-2C800ED2-57BE-4146-9790-946F2A50CF30Q53519290-1B964B88-FE1D-4091-ABF3-43DE1FFB884D
P2860
comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
comparison of two commercial a ...... er risk of cervical disorders.
@ast
comparison of two commercial a ...... er risk of cervical disorders.
@en
type
label
comparison of two commercial a ...... er risk of cervical disorders.
@ast
comparison of two commercial a ...... er risk of cervical disorders.
@en
prefLabel
comparison of two commercial a ...... er risk of cervical disorders.
@ast
comparison of two commercial a ...... er risk of cervical disorders.
@en
P2093
P2860
P1476
comparison of two commercial a ...... her risk of cervical disorders
@en
P2093
Gonneke K Harbers
Judith M J E Bakkers
Leon F A G Massuger
Maaike A P C van Ham
Wim G V Quint
P2860
P304
P356
10.1128/JCM.43.6.2662-2667.2005
P407
P577
2005-06-01T00:00:00Z